Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways
Yi‐Hua Lai(National Chung Hsing University), Jeremy J.W. Chen(National Chung Hsing University)
Cited by 14
Related Papers
The HLJ1 -targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer
|Carcinogenesis|2013|47
HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma
|Nucleic Acids Research|2010|31
AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways
|Journal of Hematology & Oncology|2017|20
Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth
|International Journal of Molecular Sciences|2022|11